Roche’s Vabysmo Reinforces Long-Term Benefits in Wet Age-Related Macular Degeneration and Shows Strong Gains in Polypoidal Choroidal Vasculopathy Paris, France – At the 25th annual Euretina Congress, one of the…
SCIEX Expands BioPhase 8800 Capabilities with Native Fluorescence Detection to Advance Protein-Based CE Assays At the 2025 CE Pharm conference, SCIEX, a global leader in life science analytical technologies, announced…
Octave Bioscience Secures $35.6 Million Series C Financing and $15.5 Million Loan to Accelerate Growth and Advance Precision Care in Neurology Octave Bioscience, Inc., a commercial-stage precision care company dedicated…
Gilead Partners With PEPFAR and Global Fund to Deliver Twice-Yearly Lenacapavir for HIV Prevention Across Low- and Lower-Middle-Income Countries Gilead Sciences, Inc. (Nasdaq: GILD) has announced a major new global…
MRM Health Secures €55 Million Series B Financing to Accelerate Development of Best-in-Class Microbiome-Based Biotherapeutics MRM Health NV, a pioneering clinical-stage biopharmaceutical company developing transformative microbiome-based therapeutics, announced the successful…
MEDIPAL Holdings and JCR Pharmaceuticals Expand Rare Disease Collaboration with Global Licensing and Japan Co-Development Agreement for JR-479, a Novel Investigational Therapy for GM2 Gangliosidosis In a significant advancement for…
Texas Expands Medical Cannabis Access with House Bill 46: A New Era for Patient For thousands of Texans who live each day with the burden of chronic pain, traumatic brain…
Purdue Pharma Expands Access to Low-Cost Opioid Use Disorder Treatment in U.S. Correctional Facilities On the occasion of International Overdose Awareness Day, Purdue Pharma L.P. (“Purdue”) announced an expansion of…
Neurotech Pharmaceuticals Strengthens Leadership with Appointment of Dr. Peter J. McDonnell to Board of Directors Neurotech Pharmaceuticals, Inc., a privately held biotechnology company pioneering transformative therapies for chronic eye diseases,…
Enlaza Therapeutics and Vertex Pharmaceuticals Forge Multi-Billion-Dollar Collaboration to Advance Next-Generation Covalent Biologics in Autoimmune Diseases and Conditioning Therapies Enlaza Therapeutics (“Enlaza” or the “Company”), a pioneering biotechnology firm and…
CapVest to Acquire Majority Stake in STADA from Bain Capital and Cinven CapVest Partners LLP (“CapVest”), a global investment firm with a reputation for building essential businesses across healthcare, consumer,…
Daiichi Sankyo Advances Cardiovascular Care with Development of Oral Triple Combination Lipid-Lowering Tablets A New Chapter in Cholesterol Management Daiichi Sankyo Europe has unveiled an ambitious new initiative: the development…